Adams-Campbell Selected for Top Award in Preventive Oncology
(March 28, 2021) — Lucile Adams-Campbell, PhD, professor of oncology and associate director for minority health and health disparities research at Georgetown Lombardi Comprehensive Cancer Center, will receive the Joseph F. Fraumeni, Jr., Distinguished Achievement Award from the American Society of Preventive Oncology.
The honor will be bestowed virtually on March 29 at the organization’s 45th annual meeting.
The award is given annually to a scientist “with outstanding achievements in the area of preventive oncology, cancer control, and/or cancer prevention.” Adams-Campbell was selected for her leadership of major collaborative projects such as the Black Women’s Health Study and her work related to health disparities.
A Moral Calling and Societal Imperative
The District of Columbia has one of the highest cancer mortality rates in the U.S., and African-Americans are at the greatest risk. As a native and longtime resident of D.C. and the first African-American woman in the country to earn a doctorate in epidemiology, Adams-Campbell believes that is unacceptable. Through Georgetown Lombardi’s Office of Minority Health (OMH) and Capital Breast Care Center (CBCC), she has addressed gaps in cancer prevention, diagnosis and treatment among minority populations.

The greatest health disparities exist east of the Anacostia River in southeast Washington, D.C., where African Americans make up approximately 90 percent of the population. Led by Adams-Campbell, the OMH and CBCC offices in southeast D.C. are staffed by experts in cancer epidemiology, health communications, exercise physiology and nutrition, as well as nurse practitioners and community health educators. Together, they work to promote evidence-based nutrition and physical activity interventions to reduce the impact of health disparities.
Part of the OMH, the CBCC has provided over 16,000 women throughout the Washington, D.C., area with cancer screenings since 2004. The CBCC also provides culturally sensitive patient navigation and health education, empowering minority women — who have often been grossly underrepresented in research studies — to make more informed decisions about their health.
In 2020, Adams-Campbell led the effort to designate the cancer center a member of the National Cancer Institute’s Community Oncology Research Program (NCORP). Georgetown Lombardi’s “National Capital Area Minority/Underserved NCORP,” or NCA-NCORP, is part of a nationwide network that aims to bring cancer clinical trials and cancer care delivery studies to people living in underserved areas.
The $5.33 million grant to establish the NCA-NCORP also allows Georgetown Lombardi researchers to increase awareness and provide access to cancer clinical trials among underserved populations in the Washington area.
Selfless Accomplishments, Esteemed Positions

In addition to her other duties, Adams-Campbell serves as the associate dean of community health and outreach for Georgetown University Medical Center and the program director of the master’s in epidemiology program at Georgetown University. She was elected to the National Academy of Medicine and the Institute of Medicine’s National Cancer Policy Forum, where she promotes in-depth discussions and action plans around cancer prevention and treatment.
In 2015, the American Association for Cancer Research (AACR) awarded Adams-Campbell the Minorities in Cancer Research Jane Cooke Wright Lectureship. She has served as chair of the AACR’s Women in Cancer Research Council and as a member of its Science Policy and Government Affairs Committee.
Adams-Campbell is also a member of the Board of Scientific Counselors for the National Human Genome Research Institute (NHGRI), for which she systematically reviews NHGRI’s intramural program and advises the NHGRI scientific director.
For her outstanding contributions to the fields of public health and health sciences, Adams-Campbell has received gold medallions from both her alma maters, Drexel University, where she received her bachelor’s and master’s degrees, and the University of Pittsburgh, where she completed her doctoral degree. In 2018, she was named a 2018 Washingtonian of the Year by Washingtonian magazine. “It has been an honor and privilege to work on behalf of D.C. residents through a leading institution and with dedicated colleagues who truly embody our commitment to justice. As long as health disparities continue to impact populations in this city, we have more work to do,” Adams-Campbell said.
-
Adams-Campbell Selected for Top Award in Preventive Oncology
(March 28, 2021) — Lucile Adams-Campbell, PhD, professor of oncology and associate director for minority health and health disparities research at Georgetown Lombardi Comprehensive Cancer Center, will receive the Joseph F. Fraumeni, Jr., Distinguished Achievement Award from the American Society of Preventive Oncology. The honor will be bestowed virtually on March 29 at the organization’s […]
Category: Special Stories
-
Music to Our Ears: Georgetown Lombardi’s Arts & Humanities Program Receives National Endowment for the Arts Grant
(February 14, 2021) — In February, the Georgetown Lombardi Arts & Humanities Program (AHP) was awarded a grant from the National Endowment for the Arts (NEA) to study the effect of music on ICU patients’ neurologic and physiologic responses. The award appears to be the first time GUMC has received research funding from the NEA. […]
Category: Lombardi Stories
-
Mechanism for How Pancreatic Cancer Evades Immunotherapy Elucidated
Discovery could lead to new or improved therapeutic options. WASHINGTON (January 28, 2021) — Pancreatic cancer, one of the most lethal of all cancers, is capable of evading attacks by immune cells by changing its microenvironment so that the immune cells suppress, rather than support, an attack on the tumor, according to a study led […]
Category: News Release
-
Male Breast Cancer Patients Face High Prevalence of Heart Disease Risk Factors
Findings indicate greater need for involvement of cardiologists, cardio-oncologists in this rarer patient population WASHINGTON (January 25, 2021) — Male breast cancer patients were found to have a high prevalence of cardiovascular conditions, in a small study of this rare patient population presented at the American College of Cardiology’s Advancing the Cardiovascular Care of the […]
Category: News Release
-
Glynda’s Story: A Chance to Advance Treatment for Aggressive Cancer
(January 11, 2021) — Inspired by the kindness, proficiency and dedication of her health care team at Georgetown Lombardi Comprehensive Cancer Center, Glynda Brown, a 52-year-old Maryland resident, felt determined to “pay it forward” and make a positive difference for future patients by participating in a clinical trial after she was diagnosed with triple-negative breast […]
Category: Lombardi Stories
-
Disrupting the Cellular Process That Promotes Pancreatic Cancer’s Deadly Growth
WASHINGTON (December 8, 2020) — Researchers say they’ve identified a way to disrupt a process that promotes the growth of pancreatic cancers — one of the most difficult and deadly cancers to treat. The team, led by scientists at Georgetown Lombardi Comprehensive Cancer Center and including investigators from Lawrence Livermore National Laboratories, STCube and Fluidigm, […]
Category: News Release
-
Smoking, Tobacco Use Among Teens Continues to Drop Even as Use of E-cigs Grows
WASHINGTON (December 2, 2020) — Despite the increase in use of e-cigarettes among adolescents, cigarette and smokeless tobacco prevalence declined more rapidly between 2012 and 2019 than in previous periods, according to a new study. The analysis by Georgetown University and the University of Michigan shows that past 30-day and daily use of both cigarettes […]
Category: News Release
-
Space Travel Can Adversely Impact Energy Production in a Cell
WASHINGTON (November 25, 2020) — Studies of both mice and humans who have traveled into space reveal that critical parts of a cell’s energy production machinery, the mitochondria, can be made dysfunctional due to changes in gravity, radiation exposure and other factors, according to investigators at Georgetown Lombardi Comprehensive Cancer Center. These findings are part […]
Category: News Release
-
Boosting Stem Cell Activity Can Enhance Immunotherapy Benefits
WASHINGTON (November 23, 2020) — Immune-system T cells have been reprogrammed into regenerative stem cell-like memory (TSCM) cells that are long-lived, highly active “super immune cells” with strong antitumor activity, according to new research from Georgetown Lombardi Comprehensive Cancer Center. The reprogramming involves a novel approach the researchers developed that inhibits the activity of proteins […]
Category: News Release
-
Georgetown Lombardi Oncologists Encourage Patients to Keep Up with Cancer Screenings
(November 20, 2020) — If you’re due for a routine cancer screening test, you should contact your doctor to find out if it can be safely deferred until the risk of COVID-19 goes down. In contrast, if you have symptoms that could be a sign of cancer, don’t delay and don’t let the pandemic discourage […]
Category: Lombardi Stories